valu squamou cell carcinoma antigen patient advanc cervic cancer neoadjuv chemotherapi serum level squamou cell carcinoma antigen sampl patient cervic cancer ninety-seven patient primari tumor recurr diseas serum sampl cycl chemotherapi surgeri week surgeri interv follow-up patient advanc cervic cancer neoadjuv chemotherapi squamou cell carcinoma antigen serum level ng/ml patient primari tumor patient recurr carcinoma percentag posit stage squamou cell tumor adenocarcinoma pretreat squamou cell carcinoma antigen level predict neoadjuv chemotherapi respons serial measur chemotherapi good correl clinic respons patient surgeri squamou cell carcinoma antigen posit find lymph node statu cervic parametri infiltr disease-fre surviv patient squamou cell carcinoma antigen pretreat valu ng/ml patient marker ng/ml abnorm squamou cell carcinoma antigen serum level clinic detect recurr patient median lead time month 